These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
142 related items for PubMed ID: 9366445
1. Recombinant T cell receptor molecules can prevent and reverse experimental autoimmune encephalomyelitis: dose effects and involvement of both CD4 and CD8 T cells. Kumar V, Coulsell E, Ober B, Hubbard G, Sercarz E, Ward ES. J Immunol; 1997 Nov 15; 159(10):5150-6. PubMed ID: 9366445 [Abstract] [Full Text] [Related]
4. Experimental autoimmune encephalomyelitis-resistant mice have highly encephalitogenic myelin basic protein (MBP)-specific T cell clones that recognize a MBP peptide with high affinity for MHC class II. Abromson-Leeman S, Alexander J, Bronson R, Carroll J, Southwood S, Dorf M. J Immunol; 1995 Jan 01; 154(1):388-98. PubMed ID: 7527816 [Abstract] [Full Text] [Related]
5. Monoclonal antibody against T-cell receptor alphabeta induces self-tolerance in chronic experimental autoimmune encephalomyelitis. Lavasani S, Dzhambazov B, Andersson M. Scand J Immunol; 2007 Jan 01; 65(1):39-47. PubMed ID: 17212765 [Abstract] [Full Text] [Related]
6. Immunodominant framework region 3 peptide from TCR V beta 8.2 chain controls murine experimental autoimmune encephalomyelitis. Kumar V, Tabibiazar R, Geysen HM, Sercarz E. J Immunol; 1995 Feb 15; 154(4):1941-50. PubMed ID: 7530748 [Abstract] [Full Text] [Related]
11. Modulation of CD4 co-receptor limits spontaneous autoimmunity when high-affinity transgenic TCR specific for self-antigen is expressed on a genetically resistant background. Illés Z, Waldner H, Reddy J, Anderson AC, Sobel RA, Kuchroo VK. Int Immunol; 2007 Oct 01; 19(10):1235-48. PubMed ID: 17804690 [Abstract] [Full Text] [Related]
12. Regulation of experimental autoimmune encephalomyelitis by CD4+, CD25+ and CD8+ T cells: analysis using depleting antibodies. Montero E, Nussbaum G, Kaye JF, Perez R, Lage A, Ben-Nun A, Cohen IR. J Autoimmun; 2004 Aug 01; 23(1):1-7. PubMed ID: 15236747 [Abstract] [Full Text] [Related]
18. Blockade of CD28 during in vitro activation of encephalitogenic T cells or after disease onset ameliorates experimental autoimmune encephalomyelitis. Perrin PJ, June CH, Maldonado JH, Ratts RB, Racke MK. J Immunol; 1999 Aug 01; 163(3):1704-10. PubMed ID: 10415078 [Abstract] [Full Text] [Related]
20. CD28 costimulation is crucial for the development of spontaneous autoimmune encephalomyelitis. Oliveira-dos-Santos AJ, Ho A, Tada Y, Lafaille JJ, Tonegawa S, Mak TW, Penninger JM. J Immunol; 1999 Apr 15; 162(8):4490-5. PubMed ID: 10201986 [Abstract] [Full Text] [Related] Page: [Next] [New Search]